Literature DB >> 26364812

Involvement of oxidative stress and mitochondrial/lysosomal cross-talk in olanzapine cytotoxicity in freshly isolated rat hepatocytes.

Aziz Eftekhari1,2,3,4, Yadollah Azarmi2,3, Alireza Parvizpur2,3, Mohammad Ali Eghbal2,3.   

Abstract

1. Olanzapine (OLZ) is a widely used atypical antipsychotic agent for the treatment of schizophrenia and other disorders. Serious hepatotoxicity and elevated liver enzymes have been reported in patients receiving OLZ. However, the cellular and molecular mechanisms of the OLZ hepatotoxicity are unknown. 2. In this study, the cytotoxic effect of OLZ on freshly isolated rat hepatocytes was assessed. Our results showed that the cytotoxicity of OLZ in hepatocytes is mediated by overproduction of reactive oxygen species (ROS), mitochondrial potential collapse, lysosomal membrane leakiness, GSH depletion and lipid peroxidation preceding cell lysis. All the aforementioned OLZ-induced cellular events were significantly (p < 0.05) prevented by ROS scavengers, antioxidants, endocytosis inhibitors and adenosine triphosphate generators. Also, the present results demonstrated that CYP450 is involved in OLZ-induced oxidative stress and cytotoxicity mechanism. 3. It is concluded that OLZ hepatotoxicity is associated with both mitochondrial/lysosomal involvement following the initiation of oxidative stress in hepatocytes.

Entities:  

Keywords:  Hepatotoxicity; ROS formation; liver damage; mitochondrial/lysosomal dysfunction; olanzapine

Mesh:

Substances:

Year:  2015        PMID: 26364812     DOI: 10.3109/00498254.2015.1078522

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  9 in total

1.  Venlafaxine-Induced Cytotoxicity Towards Isolated Rat Hepatocytes Involves Oxidative Stress and Mitochondrial/Lysosomal Dysfunction.

Authors:  Elham Ahmadian; Hossein Babaei; Alireza Mohajjel Nayebi; Aziz Eftekhari; Mohammad Ali Eghbal
Journal:  Adv Pharm Bull       Date:  2016-12-22

2.  Effect of alpha-mangostin on olanzapine-induced metabolic disorders in rats.

Authors:  Alireza Ardakanian; Mahboobeh Ghasemzadeh Rahbardar; Farzaneh Omidkhoda; Bibi Marjan Razavi; Hossein Hosseinzadeh
Journal:  Iran J Basic Med Sci       Date:  2022-02       Impact factor: 2.532

3.  Analysis of Mitochondrial Function in Cell Membranes as Indicator of Tissue Vulnerability to Drugs in Humans.

Authors:  Ane Elexpe; Laura Sánchez-Sánchez; Tarson Tolentino-Cortez; Egoitz Astigarraga; María Torrecilla; Gabriel Barreda-Gómez
Journal:  Biomedicines       Date:  2022-04-23

Review 4.  Psychiatric drugs impact mitochondrial function in brain and other tissues.

Authors:  Shawna T Chan; Michael J McCarthy; Marquis P Vawter
Journal:  Schizophr Res       Date:  2019-11-16       Impact factor: 4.939

5.  High-protein diet and omega-3 fatty acids improve redox status in olanzapine-treated rats.

Authors:  Miroslav Mitrovic; Tamara Nikolic Turnic; Vladimir Zivkovic; Zarko Pavic; Aleksandra Vranic; Ivan Srejovic; Jasmina Sretenovic; Sergey Bolevich; Vladimir Lj Jakovljevic
Journal:  Mol Cell Biochem       Date:  2020-03-23       Impact factor: 3.396

6.  Differential mitochondrial DNA copy number in three mood states of bipolar disorder.

Authors:  Dong Wang; Zongchang Li; Weiqing Liu; Jun Zhou; Xiaoqian Ma; Jinsong Tang; Xiaogang Chen
Journal:  BMC Psychiatry       Date:  2018-05-25       Impact factor: 3.630

7.  Peripheral non-enzymatic antioxidants in patients with schizophrenia: a case-control study.

Authors:  Zhe Lu; Tianyang Wen; Yingtan Wang; Weijing Kan; Guanglei Xun
Journal:  BMC Psychiatry       Date:  2020-05-15       Impact factor: 3.630

Review 8.  Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain.

Authors:  Diana Grajales; Vitor Ferreira; Ángela M Valverde
Journal:  Cells       Date:  2019-10-29       Impact factor: 6.600

9.  N-acetylcysteine prevents olanzapine-induced oxidative stress in mHypoA-59 hypothalamic neurons.

Authors:  Zehra Boz; Minmin Hu; Yinghua Yu; Xu-Feng Huang
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.